Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian C Kohler

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Policy and Practice|August 19, 2022
State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccinesAriel Gorodensky, Jillian C Kohler
Globalization and Health|March 25, 2017
Matching safety to access: global actors and pharmacogovernance in Kenya- a case studyKathy Moscou, Jillian C Kohler
BMC Medicine|June 27, 2020
Why the COVID-19 pandemic should be a call for action to advance equitable access to medicinesJillian C Kohler, Tim K Mackey
Globalization and Health|September 26, 2020
Social capital and public health: responding to the COVID-19 pandemicAnna S Y Wong, Jillian C Kohler
Globalization and Health|September 19, 2021
The Global Fund: why anti-corruption, transparency and accountability matterZhihao Chang, Violet Rusu, Jillian C Kohler
Journal of Pharmaceutical Policy and Practice|February 11, 2016
Governance and pharmacovigilance in Brazil: a scoping reviewKathy Moscou, Jillian C Kohler, Anita MaGahan
Journal of Pharmaceutical Policy and Practice|September 23, 2015
Policy versus practice: a community-based qualitative study of the realities of pharmacy services in Nunavut, CanadaSandra J Romain, Jillian C Kohler, Kue Young
BMC International Health and Human Rights|May 5, 2012
Corruption in the health care sector: A barrier to access of orthopaedic care and medical devices in UgandaMaryse Bouchard, Jillian C Kohler, James Orbinski, et al.
Journal of Global Health|December 8, 2023
Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviewsAriel Gorodensky, Quinn Grundy, Navindra Persaud, et al.
Globalization and Health|October 31, 2009
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makersHabibat A Garuba, Jillian C Kohler, Anna M Huisman
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Policy and Practice|August 19, 2022
State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccinesAriel Gorodensky, Jillian C Kohler
Globalization and Health|March 25, 2017
Matching safety to access: global actors and pharmacogovernance in Kenya- a case studyKathy Moscou, Jillian C Kohler
BMC Medicine|June 27, 2020
Why the COVID-19 pandemic should be a call for action to advance equitable access to medicinesJillian C Kohler, Tim K Mackey
Globalization and Health|September 26, 2020
Social capital and public health: responding to the COVID-19 pandemicAnna S Y Wong, Jillian C Kohler
Globalization and Health|September 19, 2021
The Global Fund: why anti-corruption, transparency and accountability matterZhihao Chang, Violet Rusu, Jillian C Kohler
Journal of Pharmaceutical Policy and Practice|February 11, 2016
Governance and pharmacovigilance in Brazil: a scoping reviewKathy Moscou, Jillian C Kohler, Anita MaGahan
Journal of Pharmaceutical Policy and Practice|September 23, 2015
Policy versus practice: a community-based qualitative study of the realities of pharmacy services in Nunavut, CanadaSandra J Romain, Jillian C Kohler, Kue Young
BMC International Health and Human Rights|May 5, 2012
Corruption in the health care sector: A barrier to access of orthopaedic care and medical devices in UgandaMaryse Bouchard, Jillian C Kohler, James Orbinski, et al.
Journal of Global Health|December 8, 2023
Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviewsAriel Gorodensky, Quinn Grundy, Navindra Persaud, et al.
Globalization and Health|October 31, 2009
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makersHabibat A Garuba, Jillian C Kohler, Anna M Huisman
Pageof 3